OncoMatch/Clinical Trials/NCT05439005

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Is NCT05439005 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies Dexmedetomidine for breast cancer.

Phase 3RecruitingInstitut CurieNCT05439005Data as of May 2026

Treatment: Dexmedetomidine — This study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.

Check if I qualify

Extracted eligibility criteria

Cancer type

Breast Carcinoma

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify